Pharma Journalist -

Kuur Therapeutics announced the launch of its new business in partnership with Baylor College of Medicine and Baylor’s Center for Cell and Gene Therapy. Houston-based Kuur Therapeutics…
Read More...

Bristol Myers Squibb Company announced that Opdivo (nivolumab) 1 mg/kg plus Yervoy (ipilimumab) 3 mg/kg (injections for intravenous use) was approved by the U.S. Food and Drug…
Read More...

WindMIL Therapeutics, a clinical-stage company developing marrow-infiltrating lymphocytes (MILs) for cancer immunotherapy, and Cognate BioServices, Inc., a leading contract development…
Read More...

Chime Biologics announced operations as an independent and stand-alone Biologics CDMO company. With the separation from JHL Biotech complete, Chime Biologics is now focused on…
Read More...

InMed Pharmaceuticals Inc. reported completed enrollment in its first Phase 1 clinical trial with INM-755 in healthy subjects (Study 755-101-HV). INM-755 is a CBN cream intended as a…
Read More...

Phio Pharmaceuticals Corp. a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic…
Read More...

The FDA has been added to the agenda for Smithers' 9th Extractables and Leachables USA Conference, taking place in Bethesda, MD, April 20-22, 2020. Alan Hood, Research Toxicologist…
Read More...

Novavax, Inc. a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the Coalition for Epidemic Preparedness Innovations…
Read More...

SMi Reports: There will be a workshop surrounding ‘Developing apps for Connected Drug Delivery’ for Injectable Drug Delivery 2020 The Injectable Drug Delivery conference will…
Read More...

COVID-19 Therapeutics Accelerator will coordinate R&D efforts and remove barriers to drug development and scale-up to address the epidemic The Bill & Melinda Gates…
Read More...